Wearable activity monitors offer oncology care teams an unbiased glimpse into patients' health behaviors and improved reports on performance status.
The US Preventive Services Task Force conducted a review of trials and cohort studies to support an update of its cervical cancer screening recommendations for women ages 21 to 65 and older.
Information patients find online can be a great concern for oncology nurses, especially when a diagnosis has an uncertain prognosis. In this follow-up study, researchers in Boston sought to determine the quality of the online resources patients with cancer, particularly pancreas, are finding.
Cesium chloride is not approved by the FDA to treat cancer or any other disease.
The attending surgeon is associated with variation in the receipt of genetic testing after breast cancer diagnosis.
Because most reconstructive surgeons are not trained in communicating complex risk information, some women may choose to have the procedure done without fully understanding the risks.
In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.
Researchers found that 31% of survivors were not concerned about their future health and that 40% were not concerned about developing cancer.
Study results provide important evidence of efficacy associated with the implementation of the Affordable Care Act during this time of debate about healthcare reform.
A bedside visual art intervention may help with cancer patients' pain, anxiety, and mood.
Despite its widespread use, there are still underrepresented groups in genetic testing for cancer.
Since the legalization of medical marijuana, clinicians must come up with appropriate responses to requests for treatment in pediatric end-of-life settings.
The Medicare Shared Savings Program has been linked to a reduction in breast cancer and an increase in colorectal cancer screenings.
The impact of the ACA on health insurance access among women diagnosed with a gynecologic cancer was previously unestablished.
Inflated medical costs may affect patients' treatment decisions as out-of-pocket costs increase.
Depending on the type of screening test used, the magnitude of harm ranges from moderate to substantial.
Survival trends increased up to 5% for cancers of the liver, pancreas, and lung.
Patients in higher quintiles of lung cancer risk had significantly more diagnoses of lung cancer.
The elimination of cost sharing for screening mammography is associated with increased screening rates.
The FDA has approved Lynparza to treat metastatic breast cancer caused by a BRCA gene mutation.
Risk-based criteria would screen high-risk smokers currently ineligible for screening using USPSTF criteria, resulting in more modest decreases in lung cancer screening.
A deep learning algorithm can detect metastases in sections of lymph nodes, and a deep learning system is effective for identifying diabetic retinopathy.
Researchers found that multimodal screening is both more expensive and more effective in reducing ovarian cancer mortality over a lifetime.
Physicians with social network member with breast cancer poor prognosis more likely to recommend screening.
The FDA has approved Ogivri to treat breast and gastric or gastroesophageal junction adenocarcinoma cancers.
Improvements in cancer survival were limited to patients with private or Medicare insurance.
Researchers found that 3 attributes had highest potential for lowering cost without compromising care.
For both genders, grief reactions were linked to emotional distress among those at high levels of burnout.
The ASCO has recommended that those with advanced cancer should receive dedicated palliative care services.
Cancer is a mysterious disease for many reasons. Chief among the unknowns are how and why tumors form. The team discovered that cancerous cells actively recruit healthy cells into tumors by extending a cable of sorts to grab their neighbors--both cancerous and healthy--and reel them in.